Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher M. Andreoli, M.D.

Co-Author

This page shows the publications co-authored by Christopher Andreoli and Joan Miller.
Connection Strength

0.862
  1. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol. 2007 Nov; 18(6):502-8.
    View in: PubMed
    Score: 0.407
  2. Miller JW, Andreoli CM. Preface. Int Ophthalmol Clin. 2007; 47(2):xv.
    View in: PubMed
    Score: 0.384
  3. Yonekawa Y, Andreoli C, Miller JB, Loewenstein JI, Sobrin L, Eliott D, Vavvas DG, Miller JW, Kim IK. Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol. 2013 Jul; 156(1):29-35.e2.
    View in: PubMed
    Score: 0.037
  4. Cohen SJ, Chan RV, Keegan M, Andreoli CM, Borenstein JT, Miller JW, Gragoudas ES. Evaluation of tissue interactions with mechanical elements of a transscleral drug delivery device. Pharmaceutics. 2012 Mar 12; 4(1):212-29.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.